CTOs on the Move

Thrasos Therapeutics

www.thrasos.com

 
Thrasos is a private, clinical-stage biotherapeutics company focused on delivering new solutions to individuals affected by kidney disease. The company's lead compound, THR-184 is currently being evaluated in a Phase 2 clinical study for the prevention of AKI in patients undergoing cardiac surgery. Thrasos is also developing compounds for diabetic nephropathy, a major cause of chronic kidney disease
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million
  • www.thrasos.com
  • 2000 Rue Peel
    Montreal, AB CAN H3A 2W5
  • Phone: 514.940.2714

Executives

Name Title Contact Details

Similar Companies

Aminex Therapeutics

Aminex Therapeutics, Inc. is focused on bringing its breakthrough discoveries to the clinic to improve the lives of cancer patients.

Enzymatics

Enzymatics is a Beverly, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

180 Life Sciences

Leading Research into Solving one of the World`s Largest Drivers of Disease: Inflammation

PathoGenetix

PathoGenetix is a Woburn, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Hexagon Bio

Hexagon Bio is a data-driven biotech developing targeted small molecule therapeutics.